Protara Therapeutics, Inc(NASDAQ:TARA) 
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformation...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.17
H 4.26
L 3.90
C 3.90
V 332,105
10EMA 3.90
20EMA 3.90
60EMA 3.90
120EMA 3.90
250EMA 3.90